HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,500
+50 (0.48%)
Apr 29, 2026, 3:30 PM KST
-11.39%
Market Cap 136.41B
Revenue (ttm) 535.14B
Net Income (ttm) -2.15B
Shares Out 12.99M
EPS (ttm) -162.00
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (1.91%)
Ex-Dividend Date Feb 26, 2026
Volume 18,193
Average Volume 23,517
Open 10,460
Previous Close 10,450
Day's Range 10,400 - 10,770
52-Week Range 9,990 - 14,250
Beta 0.39
RSI 49.42
Earnings Date May 13, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2025, HANDOK's revenue was 535.14 billion, an increase of 5.48% compared to the previous year's 507.36 billion. Losses were -2.15 billion, -95.90% less than in 2024.

Financial Statements

News

There is no news available yet.